Granix (tbo-filgrastim) NDC 63459-918

Product information

Brand name (proprietary)

Granix

Generic name (nonproprietary)

tbo-filgrastim

Active ingredients

Filgrastim — 300 ug/mL

Dosage form

Injection, Solution

Route

Subcutaneous

Labeler

Cephalon, LLC

Product type

Prescription drug

Marketing category

BLA — Biologics License ApplicationApplication BLA 125294

Marketing start

Nov 7, 2018

Listing expires

Dec 31, 2027

Other FDA classes

Granulocyte Colony-Stimulating Factor (Chemical structure)Increased Myeloid Cell Production (Physiologic effect)

Identifiers

Product ID 63459-918_bebf458b-946a-4cc0-b565-5e2637f48cb2SPL ID bebf458b-946a-4cc0-b565-5e2637f48cb2

Pharmacologic class

Leukocyte Growth Factor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463459091859 followed by a unit qualifier and the quantity Copy

Package 63459-0918-59. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125294

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.